Psoriatic Arthritis News

Psoriasis is “mostly mild” in patients with psoriatic arthritis yet still impacts quality of life when measured using a dermatology-specific questionnaire, according to data published in Rheumatology.

Sex and gender differences between patients with psoriatic arthritis and axial spondyloarthritis may explain why women experience longer diagnostic delays, higher burden and lower drug survival in these diseases, noted a speaker here.

Providers should avoid monotherapy when treating hidradenitis suppurativa, and instead use a “layered and rotated” approach that also addresses the isolating psychosocial aspects of the disease, noted a speaker here.

A broader array of therapies is allowing clinicians to target specific disease domains in psoriatic arthritis, but the treat-to-target “sweet spot” remains unclear, noted a presenter at the 2021 Congress of Clinical Rheumatology-East.

Dermatologists should be prepared to discuss COVID-19 vaccines with their patients who have immune-mediated inflammatory diseases and how biologic treatments may be affected, according to a review.

Both men and women of reproductive age with psoriatic arthritis who are hoping to be parents should consult their medical team and adhere to medications, according to a speaker at the 2021 Rheumatology Nurses Society annual conference.

Shared features and clinical presentations can make diagnosis and management of psoriatic arthritis, non-radiographic axial spondyloarthritis and reactive arthritis particularly challenging, according to a speaker at the 2021 Rheumatology Nurses Society annual conference.

Analgesic opioid use was higher among individuals with psoriasis and those with concomitant psoriasis and psoriatic arthritis compared with the general population, according to findings from a cross-sectional study conducted in Denmark.

The use of biological disease-modifying antirheumatic drugs in patients with psoriasis reduces the risk for psoriatic arthritis, according to data published in the Annals of the Rheumatic Diseases.

Approximately 18% of patients in a rheumatic disease registry used cannabis in 2019, up from 6.3% in 2014, with the highest prevalence occurring in states where its use is legal, according to data published in Arthritis Care & Research.